Prediction of clinical trial enrollment rates
- PMID: 35202402
- PMCID: PMC8870517
- DOI: 10.1371/journal.pone.0263193
Prediction of clinical trial enrollment rates
Abstract
Clinical trials represent a critical milestone of translational and clinical sciences. However, poor recruitment to clinical trials has been a long standing problem affecting institutions all over the world. One way to reduce the cost incurred by insufficient enrollment is to minimize initiating trials that are most likely to fall short of their enrollment goal. Hence, the ability to predict which proposed trials will meet enrollment goals prior to the start of the trial is highly beneficial. In the current study, we leveraged a data set extracted from ClinicalTrials.gov that consists of 46,724 U.S. based clinical trials from 1990 to 2020. We constructed 4,636 candidate predictors based on data collected by ClinicalTrials.gov and external sources for enrollment rate prediction using various state-of-the-art machine learning methods. Taking advantage of a nested time series cross-validation design, our models resulted in good predictive performance that is generalizable to future data and stable over time. Moreover, information content analysis revealed the study design related features to be the most informative feature type regarding enrollment. Compared to the performance of models built with all features, the performance of models built with study design related features is only marginally worse (AUC = 0.78 ± 0.03 vs. AUC = 0.76 ± 0.02). The results presented can form the basis for data-driven decision support systems to assess whether proposed clinical trials would likely meet their enrollment goal.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures





Similar articles
-
Automated feature selection of predictors in electronic medical records data.Biometrics. 2019 Mar;75(1):268-277. doi: 10.1111/biom.12987. Epub 2019 Apr 2. Biometrics. 2019. PMID: 30353541
-
Parsable Clinical Trial Eligibility Criteria Representation Using Natural Language Processing.AMIA Annu Symp Proc. 2023 Apr 29;2022:616-624. eCollection 2022. AMIA Annu Symp Proc. 2023. PMID: 37128426 Free PMC article.
-
Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.BMC Med Inform Decis Mak. 2015 Apr 14;15:28. doi: 10.1186/s12911-015-0149-3. BMC Med Inform Decis Mak. 2015. PMID: 25881112 Free PMC article.
-
Recruitment of Black Adults into Cardiovascular Disease Trials.J Am Heart Assoc. 2021 Sep 7;10(17):e021108. doi: 10.1161/JAHA.121.021108. Epub 2021 Aug 25. J Am Heart Assoc. 2021. PMID: 34431310 Free PMC article.
-
Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.Artif Intell Med. 2019 Jul;98:109-134. doi: 10.1016/j.artmed.2019.07.007. Epub 2019 Jul 26. Artif Intell Med. 2019. PMID: 31383477 Review.
Cited by
-
Predicting accrual success for better clinical trial resource allocation.Sci Rep. 2025 Jan 31;15(1):3879. doi: 10.1038/s41598-025-88400-x. Sci Rep. 2025. PMID: 39890973 Free PMC article.
-
Enhancing site selection strategies in clinical trial recruitment using real-world data modeling.PLoS One. 2024 Mar 11;19(3):e0300109. doi: 10.1371/journal.pone.0300109. eCollection 2024. PLoS One. 2024. PMID: 38466688 Free PMC article.
-
Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning.Sci Adv. 2025 Jun 6;11(23):eadt5708. doi: 10.1126/sciadv.adt5708. Epub 2025 Jun 4. Sci Adv. 2025. PMID: 40465719 Free PMC article.
-
Discontinuation and nonpublication of clinical trials in orthopaedic oncology.J Orthop Surg Res. 2024 Feb 5;19(1):121. doi: 10.1186/s13018-024-04601-6. J Orthop Surg Res. 2024. PMID: 38317223 Free PMC article.
-
Artificial intelligence for optimizing recruitment and retention in clinical trials: a scoping review.J Am Med Inform Assoc. 2024 Nov 1;31(11):2749-2759. doi: 10.1093/jamia/ocae243. J Am Med Inform Assoc. 2024. PMID: 39259922 Free PMC article.
References
-
- Cheng SK, Dietrich MS, Dilts DM. A sense of urgency: evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies. Clinical Cancer Research. 2010;16(22):5557–5563. doi: 10.1158/1078-0432.CCR-10-0133 - DOI - PMC - PubMed
-
- Mendelsohn J, Moses HL, Nass SJ, et al.. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. National Academies Press; 2010. - PubMed
-
- Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. JNCI: Journal of the National Cancer Institute. 2019;111(3):245–255. doi: 10.1093/jnci/djy221 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources